跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Auromox
Approved
STANDARD
Auromox
Aurolab
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
90f6fd81616367b3
Company
Aurolab
Type
Standard
Approval Details
Approval Id
90f6fd81616367b3
Drug Approval Philippines Name
Auromox
Product Name
Auromox
Registration Number
DR-XY48572
Brand Name
Auromox
Generic Name
Moxifloxacin (as hydrochloride)
Dosage Form
Ophthalmic Solution (Eye Drop)
Dosage Strength
5 mg/mL (0.5% w/v)
Manufacturer
Aurolab
Importer
Brady Pharma, Inc.
Distributor
Brady Pharma, Inc.
Company Detail Path
/organization/aurolab-trust
Issuance Date
18 January 2023
Expiry Date
18 January 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
90f6fd81616367b3
Type
Standard
Back to Philippines FDA Approvals
Auromox - Philippines FDA Drug Approval Details